Supplementary Figure 2 from A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non–Small Cell Lung Cancer Patients

Abstract

<p>PDF file - 144KB, Overall survival HRs (racotumomab over placebo) in subgroups according to baseline characteristics.</p>